GLP-1 and Skincare Trends Drive Demand for Bathroom Mini Fridges
More people are storing weight-loss shots and special skin products in small fridges inside their bathrooms. Appliance makers report…
-
-
Samsung Biologics Offers $1.8 Billion to Acquire PolyPeptide
Samsung Biologics has offered to buy PolyPeptide in an all-cash deal worth approximately $1.8 billion, which translates to $55.17…
-
Viking Therapeutics: Is This GLP-1 Contender Worth Watching?
The GLP-1 drug class has become one of the hottest areas in pharma right now. Viking Therapeutics is one…
-
Online GLP-1 Sellers Often Bypass Meaningful Clinician Oversight
Direct-to-consumer telehealth platforms have changed how people access glucagon-like peptide-1 receptor agonists for managing obesity. A recent secret shopper…
-
Research Links GLP-1 Weight Loss to Higher Employment and Marriage Rates in Women
A recent study shows that starting weight loss medications can lead to significant changes in a woman’s social and…
-
NDSU and Sanford Health Launch GLP-1 Research Collaboration to Optimize Patient Outcomes
North Dakota State University and Sanford Health are teaming up for a major new research project. Together, they want…
-
Beat the Heat: Summer Advice for GLP-1 Users
GLP-1 medications like Ozempic, Wegovy, and Mounjaro help many people manage diabetes and weight loss. However, these drugs change…
-
GLP-1s and Mental Health: Current Evidence Explained
Glucagon-like peptide-1 receptor agonists have changed how we approach obesity and type 2 diabetes. Their metabolic effects are well…
-
Tirzepatide Leads Weight Loss Efficacy Among Weight Management Medications
A new meta-analysis shows that tirzepatide leads to much greater weight loss than semaglutide or liraglutide in non-diabetic patients….
-
Ozempic Face: Separating Clinical Reality From Social Media Myth
Rapid weight loss linked to GLP-1 receptor agonists has led to the term “Ozempic face.” This refers to a…
